Search hospitals

>

Kentucky

>

Louisville

University of Louisville

Claim this profile

Louisville, Kentucky 40202

Global Leader in Crohn's Disease

Global Leader in Stroke

Conducts research for Gastroparesis

Conducts research for Heart Failure

Conducts research for Gastric Stasis

476 reported clinical trials

41 medical researchers

Photo of University of Louisville in LouisvillePhoto of University of Louisville in Louisville

Summary

University of Louisville is a medical facility located in Louisville, Kentucky. This center is recognized for care of Crohn's Disease, Stroke, Gastroparesis, Heart Failure, Gastric Stasis and other specialties. University of Louisville is involved with conducting 476 clinical trials across 663 conditions. There are 41 research doctors associated with this hospital, such as Neal E. Dunlap, Rebecca Redman, MD, Robert C. Martin, MD,PhD,FACS, and Gerald W Dryden, MD, Ph.D.

Top PIs

Clinical Trials running at University of Louisville

Gastroparesis

Heart Failure

Crohn's Disease

Parkinson's Disease

Gastric Stasis

Spinal Cord Injury

Dystonia

Liver Cancer

Abdominal Aortic Aneurysm

Bleeding

Image of trial facility.

Neuromodulation, Pyloric Therapies, and Immunotherapy

for Gastroparesis

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time, regardless of whether any treatment was given or not. If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.

Recruiting

1 award

N/A

8 criteria

Image of trial facility.

Registry

for Gastroparesis

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.

Recruiting

1 award

N/A

4 criteria

Image of trial facility.

IVIG

for Gastroparesis

Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of these patients have serologic and/or endo organ abnormalities and findings consistent with autoimmune neuropathies, primarily involving the GI tract. These disorders have been known as autoimmune gastrointestinal neuropathies (GAIN) or also as autoimmune gastrointestinal dysmotility (AGID), among other terms. Some patients respond to intravenous immunoglobulin (IVIG) and this study, which is an observational clinical series, documents the patients, their findings and standardized responses to therapy with IVIG.

Recruiting

1 award

N/A

2 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Louisville?

Where is University of Louisville located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Louisville accept?

What awards or recognition has University of Louisville received?